Full Length Research Paper
References
Cenci M, De Soccio G, Recchia O (2003). Prevalence of hepatitis C virus (HCV) genotypes in central Italy. Anticancer Res. 23(6D):5123-32 | ||||
Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L (2008). Changing HCV genotypes distribution In Poland-relation to source and time of infection. J. Clin. Virol. 42(2):156-9 http://dx.doi.org/10.1016/j.jcv.2008.02.001 PMid:18353714 |
||||
Chlabicz S, Flisiak R, Lapinski TW (2011). Epidemiological features of patients infected with HCV genotype 4 in Poland. Hepat. Mon. 11(3):191-194 PMid:22087142 PMCid:PMC3206688 |
||||
Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, DuCros P, Ford N (2013). Viral hepatitis and the Global Burden of Disease: a need to regroup. J. Viral. Hepat. 20(9):600-601 http://dx.doi.org/10.1111/jvh.12123 |
||||
Elasifer HA, Agnnyia YM, Al-Alagi BA, Daw MA (2010). Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients. Virol. J. 7:317. http://dx.doi.org/10.1186/1743-422X-7-317 PMid:21073743 PMCid:PMC2993674 |
||||
Fattovich G, Ribero ML, Pantalena M, Diodati G, Almasio P, Nevens F, Tremolada F, Degos F, Rai J, Solinas A, Mura D, Tocco A, Zagni I, Fabris F, Lomonaco L, Noventa F, Realdi G, Schalm SW, Tagger A (2001). Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe. J. Viral. Hepat. 8(3):206-16 http://dx.doi.org/10.1046/j.1365-2893.2001.00291.x |
||||
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002). Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347(13):975-982 http://dx.doi.org/10.1056/nejmoa020047 |
||||
Grąbczewska E, Pawłowska M, Halota W (2003). Epidemiological aspects of HVC-HIV co-infections. HIV AIDS Rev. 2(3/4):123-26 | ||||
Guerra J, Garenne M, Mohamed MK, Fontanet A (2012). HCV burden of infection in Egypt: results from a nationwide survey. J. Viral. Hepat. 19(8):560-567 http://dx.doi.org/10.1111/j.1365-2893.2011.01576.x |
||||
Hamed ME, Kamal Alanani NM, Sherief LM, Fouad MA, Elwahab LA, Raafat N (2013). Study of non-organ-specific antibodies in children with genotype 4 chronic hepatitis C. Saudi J. Gastroenterol. 19(6):262-270 http://dx.doi.org/10.4103/1319-3767.121038 PMid:24195980 PMCid:PMC3958974 |
||||
Januszkiewicz-Lewandowska D, Wysocki J, Rembowska J (2003). Transmission of HCV infection among long-term hospitalized onco-hematological patients. J. Hosp. Infect. 53(2):120-23 http://dx.doi.org/10.1053/jhin.2002.1301 PMid:12586571 |
||||
Katsoulidou A, Sypsa V, Tassopoulos NC, Boletis J, Karafoulidou A, Ketikoglou I, Tsantoulas D, Vafiadi I, Hatzis G, Skoutelis A, Akriviadis E, Vasiliadis T, Kitis G, Magiorkinis G, Hatzakis A (2006). Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J. Viral. Hepat. 13(1):19-27 http://dx.doi.org/10.1111/j.1365-2893.2005.00649.x |
||||
Laurer GM, Walker BD (2001). Hepatitis C virus infection. N. Engl. J. Med. 345:41-52. http://dx.doi.org/10.1056/NEJM200107053450107 PMid:11439948 |
||||
Liberto MC, Marascio N, Zicca E, Matera G (2012). Epidemiological features and specificies of HCV infection: a hospital-based cohort study in a university medical center Calabria region. BMC Infect. Dis. 12(Suppl 2):S4 http://dx.doi.org/10.1186/1471-2334-12-S2-S4 PMid:23173638 PMCid:PMC3495624 |
||||
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (2013). Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57(4):1333-1342 http://dx.doi.org/10.1002/hep.26141 PMid:23172780 |
||||
Nguyen MH, Keeffe EB (2005). Prevalence and treatment of hepatitits C virus genotypes 4, 5, and 6. Clin. Gastroenterol. Hepatol. 3(10 Suppl 2): 97-101 http://dx.doi.org/10.1016/S1542-3565(05)00711-1 |
||||
Nicot F, Legrand-Abravanel F, Sandres-Saune K, Boulestin A, Dubois M, Alric L, Vinel JP, Pasquier C, Izopet J (2005). Heterogeneity of hepatitis C virus genotype 4 strains in south-western France. J. Gen. Virol. 86(1):107-114. http://dx.doi.org/10.1099/vir.0.80409-0 PMid:15604436 |
||||
Panasiuk A, Flisiak R, Mozer-Lisewska I, Adamek A, Tyczyno M, Halota W, PawÅ‚owska M, StaÅ„czak J, Berak H, Wawrzynowicz-Syczewska M, BoroÅ„-Kaczmarska A, ÅapiÅ„ski TW, Grzeszczuk A, Piekarska A, Tomasiewicz K, JabÅ‚kowski M, Kryczka W, Zarebska-Michaluk D, StepieÅ„ P, Garlicki AM, KozÅ‚owska J, WierciÅ„ska-DrapaÅ‚o A, Zasik E, Mazur W, Dobracka B, Dobracki W, Simon K, Ryzko J, PawÅ‚owska J, Dzierzanowska-Fangrat K, Januszkiewicz-Lewandowska D, Szenborn L, Zaleska I, Rokitka M, StrawiÅ„ska E, Balinowska K, Smiatacz T, Stalke P, Sikorska K, Lakomy A, Zdrojewski M, Lachowicz A (2013). Distribution of HCV genotypes in Poland. Przedl. Epidemiol. 67(1):11-6, 99-103 | ||||
Petruzziello A, Coppola N, Diodato AM, Iervolino V, Azzaro R, Di Costanzo G, Di Macchia CA, Di Meo T, Loquercio G, Pasquale G, Cacciapuoti C (2013). Age and gender distribution of hepatitis C virus genotypes in the metropolitan area of Naples. Intervirology 56(3):206-212 http://dx.doi.org/10.1159/000348506 PMid:23594735 |
||||
Ramia S, Eid-Fares J (2006). Distribution of hepatitis C virus genotypes in the Middle East. J. Infect. Dis. 10(4):272-7 | ||||
Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, Hoffman P, Hemmer R, Staub T, Seguin-Devaux C, Schmit JC (2008). Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World J. Gastroenterol. 14(8):1237-1243 http://dx.doi.org/10.3748/wjg.14.1237 PMid:18300350 PMCid:PMC2690672 |
||||
Shiffman ML (2007). Factors contributing to failure when treating patients with chronic hepatitis C virus infection. Gastroenterol. Hepatol. 3(6):4-11 | ||||
Simmonds P (2004). Genetic diversity and evolution of hepatitis C virus, 5 years on. J. Gen. Virol. 85:3173-3188 http://dx.doi.org/10.1099/vir.0.80401-0 |
||||
Stroffolini T, D'Egidio PF, Aceti A, Filippini P, Puoti M, Leonardi C, Almasio PL (2012). Hepatitis C virus infection among drug addiscts In Italy. J. Med. Virol. 84(10):1608-12 http://dx.doi.org/10.1002/jmv.23370 PMid:22930509 |
||||
Touceda S, Pereira M, Agulla A (2002). Prevalence of hepatitis C virus genotype in the areao of El Ferrol (La Coruna, Spain). Enferm. Infecc. Microbiol. Clin. 20(5):200-4 http://dx.doi.org/10.1016/S0213-005X(02)72789-4 |
||||
Tyczyno M (2007). Genotypy HCV wÅ›ród pacjentów diagnozowanych w Bydgoszczy. MSR Hepatol. 7:77-79 | ||||
Zein NN (2000). Clinical significance of hepatitis C virus genotypes. Clin. Microbiol. Rev. 13(2):223-35 http://dx.doi.org/10.1128/cmr.13.2.223-235.2000 |
||||
Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH (1996). Hepatitis C virus genotypes In United States: epidemiology, pathogenicity, and response to interferon therapy. Ann. Intern. Med. 125(8):634-639 http://dx.doi.org/10.7326/0003-4819-125-8-199610150-00002 PMid:8849147 |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0